Skip to main content
Przejdź do strony domowej Komisji Europejskiej (odnośnik otworzy się w nowym oknie)
polski pl
CORDIS - Wyniki badań wspieranych przez UE
CORDIS

Teaming to Drive the Future of Genomic Medicine

Cel

Genomic medicine is transforming healthcare through precise, personalized solutions that enhance patient outcomes. However, Portugal faces significant challenges, including limited genomic sequencing, fragmented clinical applications, and a shortage of specialized talent. i3S-HEALTH aims to address these issues by modernizing the Institute for Research and Innovation in Health (i3S) into a global Centre of Excellence in Genomic Medicine under the guidance of the European Molecular Biology Laboratory (EMBL) as an advanced partner. i3S-HEALTH will establish a state-of-the-art Genomic Medicine Hub that uniquely integrates next-generation sequencing, computational biology, AI-driven bioinformatics, and high-throughput functional genomics for new variants discovery to improve patient care. This initiative will be Portugal's first multidisciplinary platform connecting advanced genomic research with clinical diagnostics. Key expected outcomes will include expanded diagnostic capacity and accuracy, trained specialists, developing novel predictive algorithms for complex genetic conditions, and identifying actionable multi-omics biomarkers. i3S-HEALTH will enrich the genomic medicine landscape in Portugal and Europe by strategically engaging the scientific community to accelerate genomic discoveries and foster high-impact collaborations with healthcare providers, improving clinical decision-making through better diagnostics and personalized patient care. It will also collaborate with industry to co-develop innovative diagnostics and therapeutics in public-private partnerships. Increased revenues from advanced diagnostic services, strategic industry partnerships, new projects, IP development, and the launch of genomics spin-offs will ensure sustainability beyond the project. i3S-HEALTH will directly strengthen national R&I performance in genomic medicine, positioning i3S as a leading European center for innovation and excellence in genomic healthcare research.

Dziedzina nauki (EuroSciVoc)

Słowa kluczowe

Program(-y)

Temat(-y)

System finansowania

HORIZON-CSA - HORIZON Coordination and Support Actions

Wyświetl wszystkie projekty finansowane w ramach tego programu finansowania

Zaproszenie do składania wniosków

(odnośnik otworzy się w nowym oknie) HORIZON-WIDERA-2025-ACCESS-01

Wyświetl wszystkie projekty finansowane w ramach tego zaproszenia

Koordynator

I3S - INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO
Wkład UE netto
€ 12 380 480,00
Adres
RUA ALFREDO ALLEN 208
4200-135 Porto
Portugalia
Region
Continente Norte Área Metropolitana do Porto
Rodzaj działalności
Research Organisations
Linki
Koszt całkowity
€ 12 880 480,00

Uczestnicy (3)